Cardiology Activities
The Role of the Pharmacist With Cholesterol Management: Focusing on New Guidelines and PCSK9 Inhibitors
0290-0000-19-153-H01-P
This activity reviews the new cholesterol guidelines and highlights the role and evidence supporting the use of PCSK9 inhibitors in the treatment of hypercholesterolemia.
2.00
Improving Patient Access to PCSK9 Inhibitors: The Role of the Pharmacist
0290-0000-19-165-H01-P
This on-demand webinar will outline the role of PCSK9 inhibitors in the treatment of hypercholesterolemia including mechanism of action and potential adverse effects.
0.50
Clinical Considerations When Using Direct Oral Anticoagulant Reversal Agents and the Role of the Pharmacist in Patient Monitoring
0290-0000-19-120-L01-P
This activity will explore the importance of assessing bleeding risk, monitoring patients, and working with health care providers to develop policies and procedures to effectively manage patients with DOAC-associated bleeds.
8-27-2019
1.00
Novel Advances in Hereditary ATTR Amyloidosis: Payer and Specialty Pharmacy Considerations
0290-0000-19-103-H01-P
This program will analyze data supporting the use of current and emerging therapies for the treatment of hATTR.
1.50